Clinical trials
Phase 1/2 Prostatic Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
| Active, not recruiting | 6 |
| Completed | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 7 |
| Peter MacCallum Cancer Centre, Australia | 3 |
| AdvanCell Pty Limited | 1 |
| DualityBio Inc. | 1 |
| ESSA Pharmaceuticals | 1 |
| Filamon LTD | 1 |
| Genentech, Inc. | 1 |
| GlaxoSmithKline | 1 |
| OncoC4, Inc. | 1 |
| PMV Pharmaceuticals, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 22 |
| Ovarian Neoplasms | 7 |
| Breast Neoplasms | 6 |
| Colorectal Neoplasms | 6 |
| Pancreatic Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Endometrial Neoplasms | 5 |
| Lung Neoplasms | 3 |
| Melanoma | 3 |
| Neoplasm Metastasis | 3 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.